Plain-English translation of NCT07347691 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study tests whether a computer program called SmartECG-AF can predict which stroke patients will develop atrial fibrillation—a serious irregular heartbeat—by analyzing their heart tracings. You've already had a small device (an implantable cardiac monitor) placed under your skin to watch your heart rhythm over time. This study will use artificial intelligence to look at your baseline heart tracing and sort you into a risk group, then follow you to see if the computer's prediction was accurate.
Some strokes happen because of undetected irregular heartbeats that come and go unpredictably. Doctors need a better way to identify which patients are at highest risk so they can intervene early and prevent future strokes.
You likely qualify if…
You likely don't qualify if…
You will have your baseline heart tracing analyzed by the artificial intelligence program, which will assign you a risk score. You'll then be followed over time as your implanted heart monitor continuously records your heart rhythm—this is something you would be doing anyway as part of your regular care. The study team will track when and if you develop the irregular heartbeat and compare that to what the AI program predicted, helping doctors understand if this new technology can improve stroke prevention.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
South Korea